Neuromuscular Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 68.9% | 0.915 | Q1 | 81.5% |
| 2024 | 2.8 | Q2 | 58.2% | 0.885 | Q1 | 80.9% |
| 2023 | 2.7 | Q3 | 47.0% | 0.824 | Q1 | 80.6% |
| 2022 | 2.8 | Q3 | 31.2% | 0.840 | Q1 | 81.9% |
| 2021 | 3.5 | Q3 | 46.2% | 0.980 | Q1 | 86.1% |
| 2020 | — | — | 1.405 | Q1 | 91.5% | |
| 2019 | — | — | 1.177 | Q1 | 88.9% | |
| 2018 | — | — | 1.236 | Q1 | 88.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0960-8966
ISSN
1873-2364
country
GBcoverage
1991-2026